CD40 and neoplasm: Our results indicated that anti-CD40 could stimulate B lymphocytes from tumor bearing mice, which led to an increase in the expression of proteins in the antigen presentation machinery and activation of secondary responses in T lymphocytes previously exposed to tumor antigens.